Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab
182461824618246
Perifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by multinodular lesions with purulent drainage and sinus tract formation. It is classically seen in middle-aged males of African descent. The etiology of the disease is unknown; however, leading theories …
Perifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by multinodular lesions with purulent drainage and sinus tract formation. It is classically seen in middle-aged males of African descent. The etiology of the disease is unknown; however, leading theories … Continue reading "Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab"
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed to Dr. Molly Hinshaw, professor of dermatology, section chief of dermatopathology and director of the nail clinic at the University of Wisconsin School of Medicine and Public Health. Watch as Dr. Hinshaw shares her tips for performing nail biopsies. Find out what’s the safest and most usef … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrance Keaney, assistant clinical faculty of dermatology at GW School of Medicine and Health Sciences, and Howard University. Watch and find out why the FDA and Department of Justice are giving more attention to regenerative medicine in recent years. Learn how the FDA views platelet-ri … 
ABC News and other media outlets recently covered the story of the World's Smallest Skin Cancer – diagnosed by a team at Oregon Health & Science University and noted by Guinness World Records. How is technology changing melanoma detection? What’s the future?
For expert advice, I reached out to Mohs surgeon Anthony Rossi, MD, assistant attending dermatologist at Memorial Sloan Kettering … 
At ODAC 2023, we had the opportunity to learn about the latest in treatments for blistering diseases from Dr. Karl Saardi, Associate Professor and Director of Inpatient Dermatology at George Washington University. We focused on the pemphigus and pemphigoid group of diseases, which we will review and summarize here.
Pemphigus
The pemphigus group of diseases is characterized by intraepidermal auto … 